Report cover image

Mergers and Acquisitions in the IVD Market

Published Mar 27, 2018
Length 85 Pages
SKU # KLI15643712

Description

Mergers and Acquisitions in the IVD Market

Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018.

Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures and Danaher’s acquisition of Cepheid are among the specific deals discussed in the report.

The report also details acquisitions driven by the development of cutting-edge technologies such as gene editing, liquid biopsy, microbiome research, and next-generation sequencing.

Gene Editing

Liquid Biopsy

Microbiome

Next-Generation Sequencing

Automation, and the Introduction of New, Large, Automated Platforms

Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests

Connectivity

Looking to the East

Table of Contents

85 Pages
    • The Market Landscape
    • Market Trends Helping to Drive Mergers and Acquisitions
    • Methodology
    • Overview: The IVD Industry – A Changing Market
    • M&A in Selected Markets
    • Selected 2017 / 2018 Acquisitions of Note
    • The 2015-2016 Market
    • Selected 2015 / 2016 Acquisitions of Note
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.